Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
59.63
+0.89 (1.52%)
At close: Oct 3, 2025, 4:00 PM EDT
59.80
+0.17 (0.29%)
After-hours: Oct 3, 2025, 7:59 PM EDT
Novo Nordisk (NVO) Revenue by Segment
History
| Date | Diabetes | Obesity | Rare Disease |
|---|---|---|---|
| Jun 30, 2025 | 33.50B | 12.42B | 3.12B |
| Mar 31, 2025 | 33.29B | 11.40B | 2.97B |
| Dec 31, 2024 | 32.48B | 10.24B | 2.93B |
| Sep 30, 2024 | 31.14B | 8.64B | 2.75B |
| Jun 30, 2024 | 30.30B | 7.61B | 2.65B |
| Mar 31, 2024 | 28.68B | 7.05B | 2.67B |
| Dec 31, 2023 | 27.27B | 6.54B | 2.70B |
| Sep 30, 2023 | 25.33B | 5.64B | 2.74B |
| Jun 30, 2023 | 24.32B | 4.40B | 2.93B |
| Mar 31, 2023 | 23.15B | 3.35B | 3.11B |
| Dec 31, 2022 | 21.94B | 2.65B | 3.23B |
| Sep 30, 2022 | 20.90B | 2.17B | 3.21B |
| Jun 30, 2022 | 19.74B | 1.87B | 3.11B |
| Mar 31, 2022 | 18.74B | 1.61B | 3.08B |
| Dec 31, 2021 | 17.80B | 1.32B | 3.02B |
| Sep 30, 2021 | 16.61B | 1.12B | 2.98B |
| Jun 30, 2021 | 15.83B | 977.21M | 3.03B |
| Mar 31, 2021 | 15.51B | 890.75M | 3.00B |
| Dec 31, 2020 | 15.27B | 892.79M | 3.02B |
| Sep 30, 2020 | 15.81B | 950.33M | 3.14B |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.